<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Lab Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Lab Med</journal-id>
      <journal-id journal-id-type="publisher-id">ALM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Laboratory Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2234-3806</issn>
      <issn pub-type="epub">2234-3814</issn>
      <publisher>
        <publisher-name>The Korean Society for Laboratory Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23667847</article-id>
      <article-id pub-id-type="pmc">3646195</article-id>
      <article-id pub-id-type="doi">10.3343/alm.2013.33.3.196</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
          <subj-group>
            <subject>Diagnostic Hematology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A Case of CD4<sup>+</sup>T-Cell Large Granular Lymphocytic Leukemia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Jaewook</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Park</surname>
            <given-names>Chan Jeoung</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jang</surname>
            <given-names>Seongsoo</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cho</surname>
            <given-names>Young-Uk</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Sang Hyuk</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Seo</surname>
            <given-names>Eul-Ju</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chi</surname>
            <given-names>Hyun-Sook</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Suh</surname>
            <given-names>Cheolwon</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Laboratory Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Chan Jeoung Park. Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, 86 Asanbyeongwon-gil, Songpa-gu, Seoul 138-736, Korea. Tel: +82-2-3010-4508, Fax: +82-2-478-0884, <email>cjpark@amc.seoul.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>5</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>4</month>
        <year>2013</year>
      </pub-date>
      <volume>33</volume>
      <issue>3</issue>
      <fpage>196</fpage>
      <lpage>199</lpage>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>6</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>07</day>
          <month>8</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>11</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Korean Society for Laboratory Medicine.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>We report here a case of a 59-yr-old man with CD4<sup>+</sup> T-cell large granular lymphocytic leukemia (T-LGL). Peripheral blood examination indicated leukocytosis (45&#xD7;10<sup>9</sup> cells/L) that consisted of 34% neoplastic lymphoid cells. Other laboratory results indicated no specific abnormalities except for serum antinuclear antibody titer (1:640), glucose (1.39 g/L), and hemoglobin A1c (7.7%) levels. Computed tomography indicated multiple small enlarged lymph nodes (&lt;1 cm in diameter) in both the axillary and inguinal areas, a cutaneous nodule (1.5 cm in diameter) in the left suboccipital area, and mild hepatosplenomegaly. Bone marrow examination revealed hypercellular marrow that consisted of 2.4% neoplastic lymphoid cells. The neoplastic lymphoid cells exhibited a medium size, irregularly shaped nuclei, a moderate amount of cytoplasm, and large granules in the cytoplasm. Immunohistochemical analysis indicated CD3<sup>+</sup>, CD4<sup>+</sup>, T-cell receptor &#x3B2;F1<sup>+</sup>, granzyme B<sup>+</sup>, and TIA1<sup>+</sup>. Flow cytometric analysis of the neoplastic lymphoid cells revealed CD3+, cytoplasmic CD3<sup>+</sup>, CD4<sup>+</sup>, and CD7<sup>+</sup>. Cytogenetic analysis indicated an abnormal karyotype of 46,XY,inv(3)(p21q27),t(12;17)(q24.1;q21),del(13)(q14q22)[2]/46,XY[28]. The patient was diagnosed with CD4<sup>+</sup> T-LGL and received chemotherapy (10.0 mg methotrexate). This is the second case of CD4<sup>+</sup> T-LGL that has been reported in Korea.</p>
      </abstract>
      <kwd-group>
        <kwd>CD4<sup>+</sup> T-LGL skin lesion</kwd>
        <kwd>Leukocytosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>T-cell large granular lymphocytic leukemia (T-LGL) is a heterogeneous disorder that is characterized by the expansion of a discrete or monoclonal population of large granular lymphocytes in the peripheral blood (PB) [<xref ref-type="bibr" rid="B1">1</xref>].</p>
      <p>T-LGL usually expresses CD3, CD8, and T-cell receptor (TCR) &#x3B1;/&#x3B2;. CD5 and/or CD7 are variably expressed and are often aberrantly diminished on malignant circulating LGL cells [<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>]. T-LGL typically expresses cytotoxic granular proteins such as TIA1, granzyme B, and granzyme M [<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>]. Immunohistochemical analysis of bone marrow (BM) biopsies with antibodies to these antigens and CD8 can be used to confirm a diagnosis of T-LGL [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>].</p>
      <p>The clinical course of T-LGL is indolent in most cases [<xref ref-type="bibr" rid="B7">7</xref>]. CD8<sup>+</sup> T-LGL is associated with mild to moderately stable lymphocytosis, neutropenia, splenomegaly, and occasionally anemia [<xref ref-type="bibr" rid="B8">8</xref>]. Lymphadenopathy is very rare [<xref ref-type="bibr" rid="B9">9</xref>]. In addition, T-LGL demonstrates a strong association with autoimmune diseases, especially rheumatoid arthritis [<xref ref-type="bibr" rid="B8">8</xref>].</p>
      <p>In contrast, the monoclonal expansion of CD4<sup>+</sup> T-LGL has been reported only sporadically in the literature [<xref ref-type="bibr" rid="B7">7</xref>]. It is marked by its association with malignant diseases and characteristically shows the absence of cytopenia, splenomegaly, and autoimmune disease [<xref ref-type="bibr" rid="B7">7</xref>]. Here, we report a case of CD4<sup>+</sup> T-LGL.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 59-yr-old man with a skin rash that had been present for 6 months was admitted to the hospital for an evaluation. He was diagnosed with hypertension and diabetes mellitus. PB examination revealed the following: white blood cell count, 45&#xD7;10<sup>9</sup> cells/L (consisting of 34% neoplastic lymphoid cells, 10% segmented neutrophils, 47% lymphocytes, 6% monocytes, and 3% eosinophils); hemoglobin, 131 g/L; mean corpuscular volume, 90.9 fL; and 419&#xD7;10<sup>9</sup> platelets/L. Neoplastic lymphoid cells displayed large granules (<xref ref-type="fig" rid="F1">Fig. 1</xref>). PB neoplastic lymphoid cells were surface CD3<sup>+</sup>, cytoplasmic CD3<sup>+</sup>, CD4<sup>+</sup>, CD7<sup>+</sup>, CD8<sup>-</sup>, CD16<sup>-</sup>, CD19<sup>-</sup>, CD20<sup>-</sup>, and CD56<sup>-</sup> (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Other laboratory results included the following: serum antinuclear antibody titer, 1:640; glucose, 1.39 g/L; hemoglobin A1c, 7.7%; total protein/albumin, 7.1/3.9 g/dL; AST/ ALT, 12/12 IU/L; and total bilirubin, 5 g/L. Multiple small enlarged lymph nodes (&lt;1 cm in diameter) in both the inguinal and axillary areas, and mild hepatosplenomegaly were noted on the abdominal and pelvic computed tomography (CT) scans. A cutaneous nodule (1.5 cm in diameter) was also observed in the left suboccipital area, but this seemed to be a reactive enlargement of the lymph nodes. BM study revealed hypercellular marrow that consisted of 2.4% neoplastic lymphoid cells. The neoplastic lymphoid cells exhibited a medium size, irregularly shaped nuclei, a moderate amount of cytoplasm, and large granules in the cytoplasm (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Immunohistochemical analysis of the BM biopsy showed CD3<sup>+</sup>, CD4<sup>+</sup>, TCR &#x3B2;F1<sup>+</sup>, granzyme B<sup>+</sup>, and TIA1<sup>+</sup> (<xref ref-type="fig" rid="F3">Fig. 3</xref>). TCR &#x3B3; gene rearrangement by BIOMED-2 PCR assays (InVivoScribe, San Diego, CA, USA) was negative. Cytogenetic analysis indicated an abnormal karyotype: 46,XY,inv(3)(p21q27),t(12;17)(q24.1;q21), del(13)(q14q22)[2]/46,XY[28]. The patient was diagnosed with CD4<sup>+</sup> T-LGL and received chemotherapy (10.0 mg methotrexate/week for 4 months). After the treatment, PB examination indicated the following values: white blood cell count, 24&#xD7;10<sup>9</sup> cells/L with 25% neoplastic lymphoid cells; hemoglobin, 137 g/L; and 395&#xD7;10<sup>9</sup> platelets/L. The patient tolerated the treatment well, and his skin lesions improved.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>T-LGL represents 2% of the cases of monoclonal proliferation of B cell, T cell, and natural killer cell mature lymphocytic leukemia in Western countries [<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B9">9</xref>]. The male:female ratio of the reported cases is approximately one, and the majority of cases occur in the 38-72 yr age group [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>]. The patient described here was a 59-yr-old man.</p>
      <p>Despite their indolent clinical behavior, clear clinical differences exist between CD4<sup>+</sup> T-LGL and the classical CD8<sup>+</sup> T-LGL, particularly with regard to the absence of neutropenia, anemia, splenomegaly, rheumatoid arthritis, or other autoimmune diseases, and the higher incidence of association with malignant diseases in the former group [<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B11">11</xref>]. In our case, neutropenia, anemia, rheumatoid arthritis, and other autoimmune diseases were absent. Although the patient demonstrated mild splenomegaly and was not diagnosed with any associated malignant diseases, our results support the notion that CD4<sup>+</sup> T-LGL is a clonal disorder with clinicopathological characteristics that are distinct from the more common CD8<sup>+</sup> T-LGL.</p>
      <p>Only one case of CD4<sup>+</sup> T-LGL displaying skin lesions has been reported so far [<xref ref-type="bibr" rid="B7">7</xref>]. In our case, the patient presented with a skin lesion, and this skin lesion demonstrated atypical T-cell infiltration on skin biopsy. Generally, T-LGL involves the PB, BM, liver, and spleen, but our case supports the notion that CD4<sup>+</sup> T-LGL can also involve the skin.</p>
      <p>In our case, clonal T-cell proliferation was diagnosed after antinuclear antibodies were discovered, which suggests a role for the immune system in preferentially developing and expanding cytotoxic CD4<sup>+</sup> T-cell clones. There are data that support the hypothesis that T-LGL arises from sustained immune stimulation and associated tumors [<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>], but further studies are required to establish both the relationship between CD4<sup>+</sup> T-LGL and classical CD8<sup>+</sup> T-LGL, and the clinicopathological characteristics that distinguish these leukemias.</p>
      <p>In conclusion, in this report we described a 59-yr-old man with CD4<sup>+</sup> T-LGL. To the best of our knowledge, only one case of CD4<sup>+</sup> T-LGL has been reported in Korea so far [<xref ref-type="bibr" rid="B14">14</xref>], and ours is the second.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>No potential conflicts of interest relevant to this article were reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Semenzato</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Zambello</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Starkebaum</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Oshimi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Loughran</surname>
              <given-names>TP</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis</article-title>
          <source>Blood</source>
          <year>1997</year>
          <volume>89</volume>
          <fpage>256</fpage>
          <lpage>260</lpage>
          <pub-id pub-id-type="pmid">8978299</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morice</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Kurtin</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Leibson</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Tefferi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hanson</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia</article-title>
          <source>Br J Haematol</source>
          <year>2003</year>
          <volume>120</volume>
          <fpage>1026</fpage>
          <lpage>1036</lpage>
          <pub-id pub-id-type="pmid">12648073</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lundell</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hartung</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Perkins</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Bahler</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules</article-title>
          <source>Am J Clin Pathol</source>
          <year>2005</year>
          <volume>124</volume>
          <fpage>937</fpage>
          <lpage>946</lpage>
          <pub-id pub-id-type="pmid">16416744</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morice</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Jevremovic</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hanson</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>The expression of the novel cytotoxic protein granzyme M by large granular lymphocytic leukaemias of both T-cell and NK-cell lineage: an unexpected finding with implications regarding the pathobiology of these disorders</article-title>
          <source>Br J Haematol</source>
          <year>2007</year>
          <volume>137</volume>
          <fpage>237</fpage>
          <lpage>239</lpage>
          <pub-id pub-id-type="pmid">17408463</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morice</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Kurtin</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Tefferi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hanson</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B</article-title>
          <source>Blood</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>268</fpage>
          <lpage>274</lpage>
          <pub-id pub-id-type="pmid">11756181</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Osuji</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Beiske</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Randen</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Matutes</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tjonnfjord</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Catovsky</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characteristic appearances of the bone marrow in T-cell large granular lymphocyte leukaemia</article-title>
          <source>Histopathology</source>
          <year>2007</year>
          <volume>50</volume>
          <fpage>547</fpage>
          <lpage>554</lpage>
          <pub-id pub-id-type="pmid">17394489</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dos Anjos Teixeira</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Alguero Md Mdel</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Balanzategui</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>TCR&#x3B1;&#x3B2;<sup>+</sup>/CD4<sup>+</sup> large granular lymphocytosis: a new clonal T-cell lymphoproliferative disorder</article-title>
          <source>Am J Pathol</source>
          <year>2003</year>
          <volume>163</volume>
          <fpage>763</fpage>
          <lpage>771</lpage>
          <pub-id pub-id-type="pmid">12875995</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Melenhorst</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Sorbara</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kirby</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hensel</surname>
              <given-names>NF</given-names>
            </name>
            <name>
              <surname>Barrett</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Large granular lymphocyte leukaemia is characterized by a clonal T-cell receptor rearrangement in both memory and effector CD8(+) lymphocyte populations</article-title>
          <source>Br J Haematol</source>
          <year>2001</year>
          <volume>112</volume>
          <fpage>189</fpage>
          <lpage>194</lpage>
          <pub-id pub-id-type="pmid">11167801</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="book">
          <person-group person-group-type="editor">
            <name>
              <surname>Swerdlow</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Campo</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <source>WHO classification of tumors of haematopoietic and lymphoid tissues</source>
          <year>2008</year>
          <edition>4th ed</edition>
          <publisher-loc>Lyon</publisher-loc>
          <publisher-name>IARC</publisher-name>
          <fpage>272</fpage>
          <lpage>273</lpage>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olteanu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Karandikar</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Eshoa</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kroft</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>Laboratory findings in CD4(+) large granular lymphocytoses</article-title>
          <source>Int J Lab Hematol</source>
          <year>2010</year>
          <volume>32</volume>
          <fpage>e9</fpage>
          <lpage>e16</lpage>
          <pub-id pub-id-type="pmid">20089001</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garrido</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ruiz-Cabello</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>B&#xE1;rcena</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sandberg</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Cant&#xF3;n</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Monoclonal TCR-V&#x3B2;<sub>13.1</sub>+/CD4+/NKa+/CD8<sup>-/+dim</sup> T-LGL lymphocytosis: evidence for an antigen-driven chronic T-cell stimulation origin</article-title>
          <source>Blood</source>
          <year>2007</year>
          <volume>109</volume>
          <fpage>4890</fpage>
          <lpage>4898</lpage>
          <pub-id pub-id-type="pmid">17303697</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bigouret</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Hoffmann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Arlettaz</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Villard</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Colonna</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ticheli</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors</article-title>
          <source>Blood</source>
          <year>2003</year>
          <volume>101</volume>
          <fpage>3198</fpage>
          <lpage>3204</lpage>
          <pub-id pub-id-type="pmid">12480700</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wlodarski</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>O'Keefe</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Howe</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Risitano</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Rodriguez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Warshawsky</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia</article-title>
          <source>Blood</source>
          <year>2005</year>
          <volume>106</volume>
          <fpage>2769</fpage>
          <lpage>2780</lpage>
          <pub-id pub-id-type="pmid">15914562</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Song</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Yoo</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>HS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>T-cell large granular lymphocytic leukemia: A case report</article-title>
          <source>Korean J Hematol</source>
          <year>2009</year>
          <volume>44</volume>
          <fpage>139</fpage>
          <lpage>143</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>Neoplastic lymphoid cells. (A) The neoplastic lymphoid cells with large cytoplasmic granules in the peripheral blood (Wright-Giemsa stain, &#xD7;1,000). (B) The neoplastic lymphoid cells in bone marrow aspirates with a medium, irregularly shaped nuclei, a moderate amount of cytoplasm, and large cytoplasmic granules (Wright-Giemsa stain, &#xD7;1,000).</p>
      </caption>
      <graphic xlink:href="alm-33-196-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Fig. 2</label>
      <caption>
        <p>Immunophenotyping of neoplastic lymphoid cells in peripheral blood by flow cytometry. (A) Gating of neoplastic lymphoid cells with bright CD45 expression and low SSC, (B) CD4 positivity (96% among gated cells) and CD8 negativity, (C) surface CD3 positivity (95%), (D) cytoplasmic CD3 positivity (93%), and (E) CD7 positivity (73%).</p>
        <p>Abbreviations: SSC, side scatter characteristics; FSC, forward scatter characteristics.</p>
      </caption>
      <graphic xlink:href="alm-33-196-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Fig. 3</label>
      <caption>
        <p>Immunohistochemical findings in the bone marrow biopsy. (A) CD3<sup>+</sup>, (B) CD4<sup>+</sup>, (C) CD8<sup>-</sup>, (D) T-cell receptor &#x3B2;F1<sup>+</sup>, and (E) granzyme B<sup>+</sup> (immunohistochemical stain, &#xD7;400).</p>
      </caption>
      <graphic xlink:href="alm-33-196-g003"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
